These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16470908)

  • 1. Re: Ward et al. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol 2005;207:377-384.
    Jass JR
    J Pathol; 2006 Mar; 208(4):590-1. PubMed ID: 16470908
    [No Abstract]   [Full Text] [Related]  

  • 2. Microsatellite instability, mismatch repair deficiency, and colorectal cancer.
    Gryfe R; Gallinger S
    Surgery; 2001 Jul; 130(1):17-20. PubMed ID: 11436007
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Tomlinson et al. Does MSI-low exist. J Pathol 2002; 197: 6-13.
    Jass JR
    J Pathol; 2003 Feb; 199(2):267-9; author reply 269-70. PubMed ID: 12533841
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
    Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
    Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
    Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
    Svrcek M; El-Bchiri J; Chalastanis A; Capel E; Dumont S; Buhard O; Oliveira C; Seruca R; Bossard C; Mosnier JF; Berger F; Leteurtre E; Lavergne-Slove A; Chenard MP; Hamelin R; Cosnes J; Beaugerie L; Tiret E; Duval A; Fléjou JF
    J Clin Oncol; 2007 Sep; 25(27):4231-8. PubMed ID: 17878476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing.
    Gruber SB
    Gastroenterology; 2006 Feb; 130(2):577-87. PubMed ID: 16472609
    [No Abstract]   [Full Text] [Related]  

  • 8. Correspondence re: G. Anderson et al., Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res., 61: 8274-8283, 2001.
    Rubin H
    Cancer Res; 2002 Nov; 62(21):6350-1; author reply 6351. PubMed ID: 12414668
    [No Abstract]   [Full Text] [Related]  

  • 9. [Colorectal cancer: mismatch repair deficiency, genomic instability, tolerance to apoptosis and assessment of risk].
    Tronov VA; Kramarenko II; Karpukhin AV
    Vopr Onkol; 2005; 51(2):159-66. PubMed ID: 16222994
    [No Abstract]   [Full Text] [Related]  

  • 10. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors.
    Aaltonen L; Johns L; Järvinen H; Mecklin JP; Houlston R
    Clin Cancer Res; 2007 Jan; 13(1):356-61. PubMed ID: 17200375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
    Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
    Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability in colorectal cancer.
    Söreide K; Janssen EA; Söiland H; Körner H; Baak JP
    Br J Surg; 2006 Apr; 93(4):395-406. PubMed ID: 16555243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it time to abandon microsatellite instability as a pre-screen for selecting families for mutation testing for mismatch repair genes?
    Evans GD; Lalloo F; Mak T; Speake D; Hill J
    J Clin Oncol; 2006 Apr; 24(12):1960-2; author reply 1962-3. PubMed ID: 16622277
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: the state of the art.
    Valentini AM; Armentano R; Pirrelli M; Caruso ML
    Cancer Treat Rev; 2006 Dec; 32(8):607-18. PubMed ID: 17055172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
    Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
    Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mismatch repair].
    Goliasnaia NV; Tsvetkova NA
    Mol Biol (Mosk); 2006; 40(2):211-23. PubMed ID: 16637261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in the nucleotide excision repair pathway and colorectal cancer risk.
    Berndt SI; Platz EA; Fallin MD; Thuita LW; Hoffman SC; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2263-9. PubMed ID: 17119055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and molecular consequences of microsatellite instability in human cancers].
    Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
    Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.